PARP inhibitor era in ovarian cancer treatment: a systematic review and meta-analysis of randomized controlled trials

被引：0
|
作者：
István Baradács
Brigitta Teutsch
Alex Váradi
Alexandra Bilá
Ádám Vincze
Péter Hegyi
Tamás Fazekas
Balázs Komoróczy
Péter Nyirády
Nándor Ács
Ferenc Bánhidy
Balázs Lintner
机构：
[1] Semmelweis University,Department of Obstetrics and Gynecology
[2] Semmelweis University,Centre for Translational Medicine
[3] University of Pécs,Institute for Translational Medicine, Szentágothai Research Centre, Medical School
[4] Semmelweis University,Division of Pancreatic Diseases, Heart and Vascular Center
[5] Semmelweis University,Department of Urology
[6] Semmelweis University,School of Medicine
来源：
Journal of Ovarian Research | / 17卷
关键词：
Olaparib; Niraparib; Rucaparib; HRD; Homologous recombination repair;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Bevacizumab combined with chemotherapy for ovarian cancer: an updated systematic review and meta-analysis of randomized controlled trials
    Wu, Yu Shen
    Shui, Lin
    Shen, Dan
    Chen, Xiaopin
    ONCOTARGET, 2017, 8 (06) : 10703 - 10713
  • [12] Ultrasound for monitoring controlled ovarian stimulation: a systematic review and meta-analysis of randomized controlled trials
    Martins, W. P.
    Vieira, C. V. R.
    Teixeira, D. M.
    Barbosa, M. A. P.
    Dassuncao, L. A.
    Nastri, C. O.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2014, 43 (01) : 25 - 33
  • [13] Fulvestrant in the treatment of advanced breast cancer: A systematic review and meta-analysis of randomized controlled trials
    Mauri, D.
    Valachis, A.
    Polyzos, N. P.
    Mavroudis, D.
    Georgoulias, V.
    Casazza, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [14] Statin therapy in the treatment of active cancer: A systematic review and meta-analysis of randomized controlled trials
    Farooqi, Mohammed A. M.
    Malhotra, Nikita
    Mukherjee, Som D.
    Sanger, Stephanie
    Dhesy-Thind, Sukhbinder K.
    Ellis, Peter
    Leong, Darryl P.
    PLOS ONE, 2018, 13 (12):
  • [15] Fulvestrant in the treatment of advanced breast cancer: A systematic review and meta-analysis of randomized controlled trials
    Valachis, Antonis
    Mauri, Davide
    Polyzos, Nikolaos P.
    Mavroudis, Dimitris
    Georgoulias, Vassilis
    Casazza, Giovanni
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2010, 73 (03) : 220 - 227
  • [16] METFORMIN TREATMENT AND HOMOCYSTEINE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Li, S.
    Zhang, Q.
    Li, L.
    Li, Q.
    Ren, K.
    Yu, C.
    Kwong, J.
    Sun, X.
    Li, J.
    VALUE IN HEALTH, 2016, 19 (07) : A897 - A897
  • [17] Systematic Review and Meta-Analysis of Randomized Controlled Trials of Xingnaojing Treatment for Stroke
    Peng, Weijun
    Yang, Jingjing
    Wang, Yang
    Wang, Weihao
    Xu, Jianxia
    Wang, Lexing
    Xing, Zhihua
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 2014
  • [18] Benvitimod for the treatment of psoriasis: A systematic review and meta-analysis of randomized controlled trials
    Ehsan, Muhammad
    Rehman, Aqeeb Ur
    Athar, Farwa
    Mustafa, Biah
    Javed, Haseeba
    Cheema, Huzaifa Ahmad
    Ayyan, Muhammad
    Shahid, Abia
    Jafar, Uzair
    Goldust, Mohamad
    DERMATOLOGIC THERAPY, 2022, 35 (12)
  • [19] Metformin Treatment and Homocysteine: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Zhang, Qianying
    Li, Sheyu
    Li, Ling
    Li, Qianrui
    Ren, Kaiyun
    Sun, Xin
    Li, Jianwei
    NUTRIENTS, 2016, 8 (12)
  • [20] A systematic review and meta-analysis of the incidence of cancer in randomized, controlled trials of verapamil
    Dong, EW
    Connelly, JE
    Borden, SP
    Yorzyk, W
    Passov, DG
    Kupelnick, B
    Luo, DH
    Ross, SD
    PHARMACOTHERAPY, 1997, 17 (06): : 1210 - 1219
12345